#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	16	274	ANT_2____Ia	750	210	100.0	ANT_2____Ia.l15.c30.ctg.1	780	18.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ANT(2'')-Ia;Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	676	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1192	30.5	0	.	p	.	0	K29T	NONSYN	85	87	AAG	331	333	ACG	40;40;42	A;C;G	40;40;42	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2368	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1416	82.3	1	SNP	p	R234F	1	.	.	700	702	TTC	905	907	TTC	119;119;120	T;T;C	119;118;120	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2368	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1416	82.3	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1205	1207	CGT	85;85;83	C;G;T	84;85;83	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2368	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1416	82.3	0	HET	.	.	.	T180C	.	180	180	T	385	385	T	67	T,C	41,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2368	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1416	82.3	0	HET	.	.	.	C261T	.	261	261	C	466	466	C	76	C,T	44,32	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2368	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1416	82.3	0	HET	.	.	.	T999C	.	999	999	T	1204	1204	T	84	T,C	45,39	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2368	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1416	82.3	0	HET	.	.	.	C996A	.	996	996	C	1201	1201	C	84	C,A	45,38	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2368	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.3	215	15.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1160	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1876	33.3	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1626	1628	AAA	27;27;27	A;A;A	27;27;27	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1288	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1752	39.1	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1206	1208	GAA	63;62;59	G;A;A	63;62;59	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	358	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	827	22.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	164	G	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	148	C	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	126	C	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	161	T	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	181	C	181	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	132	C	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	136	A	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	135	A	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	132	A	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	127	T	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	127	C	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	118	C	118	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	117	A	117	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	114	G	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	111	C	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	117	T	117	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	162	G	162	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	171	G	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	173	T	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	176	T	176	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	166	G	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	126	C	125	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	118	A	117	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	99	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	90	C	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	41	A	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	42	A	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	36	G	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	51	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	105	T	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	112	G	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	74	T	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	781	114.9	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	221	C	219	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	C990G	SNP	990	990	C	39	39	G	32	G	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	T1002A	SNP	1002	1002	T	51	51	A	44	A	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	A1004G	SNP	1004	1004	A	53	53	G	45	G	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	C1011T	SNP	1011	1011	C	60	60	T	46	T	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	C1023A	SNP	1023	1023	C	72	72	A	46	A	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	T1024A	SNP	1024	1024	T	73	73	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	90	90	G	51	G	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.4	141	32.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	91	91	T	49	T	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	35	G	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	30	A	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	A1003C	SNP	1003	1003	A	53	53	C	30	C	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	G1008C	SNP	1008	1008	G	58	58	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	30	T	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	T1012C	SNP	1012	1012	T	62	62	C	31	C	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	C1023A	SNP	1023	1023	C	72	72	A	34	A	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	.1025G	INS	1025	1025	T	75	75	G	39	G	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	50	G	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3780	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c30.ctg.5	143	42.3	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	51	T	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	948	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1595	32.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	274	276	CGT	25;23;23	C;G;T	25;23;23	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	948	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1595	32.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	358	360	ATC	40;38;36	A;T;C	39;38;36	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	948	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1595	32.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1117	1119	GGC	34;33;33	G;G;C	34;33;33	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1428	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2188	35.0	0	.	p	.	0	R8S	NONSYN	22	24	AGA	261	263	AGC	23;24;25	A;G;C	23;23;24	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1428	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2188	35.0	0	.	p	.	0	I142L	NONSYN	424	426	ATA	663	665	CTA	33;33;33	C;T;A	33;33;33	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1428	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2188	35.0	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1182	1184	CAA	48;47;47	C;A;A	48;46;47	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1428	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2188	35.0	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1281	1283	GGT	46;44;40	G;G;T	46;44;40	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1428	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2188	35.0	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1851	1853	GTT	38;38;37	G;T;T	38;38;37	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	674	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1521	23.8	0	.	p	.	0	A125E	NONSYN	373	375	GCA	553	555	GAA	36;36;35	G;A;A	36;36;35	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	674	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1521	23.8	0	.	p	.	0	M185T	NONSYN	553	555	ATG	733	735	ACC	10;10;10	A;C;C	10;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	674	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1521	23.8	0	.	p	.	0	S225T	NONSYN	673	675	TCC	853	855	ACT	14;15;14	A;C;T	14;14;13	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	674	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1521	23.8	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1243	1245	ATC	15;15;16	A;T;C	15;14;16	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	858	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1464	31.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	1062	aad-	789	789	100.0	aad-.l15.c4.ctg.2	1303	33.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2588	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3666	37.9	0	.	p	.	0	T85I	NONSYN	253	255	ACC	530	532	ATC	46;46;48	A;T;C	46;45;48	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2588	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3666	37.9	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2243	2245	AAG	33;35;35	A;A;G	33;35;35	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2588	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3666	37.9	0	.	p	.	0	P1031S	NONSYN	3091	3093	CCG	3368	3370	TCG	30;31;31	T;C;G,A	28;30;29,1	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	958	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1605	32.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	247	249	GTC	16;13;14	G;T;C	15;13;14	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	958	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1605	32.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	988	990	TGC	45;45;46	T;G;C	45;45;46	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2354	acrF	3105	2598	98.5	acrF.l15.c4.ctg.2	3098	40.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	372	372	T	25	T	25	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2354	acrF	3105	2598	98.5	acrF.l15.c4.ctg.2	3098	40.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	678	680	GAC	44;43;43	G;A;C	43;43;43	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2354	acrF	3105	2598	98.5	acrF.l15.c4.ctg.2	3098	40.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	954	956	TTA	20;21;22	T;T;A	20;20;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2354	acrF	3105	2598	98.5	acrF.l15.c4.ctg.2	3098	40.5	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1137	1139	AAT	48;49;49	A;A;T	48;49;49	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2354	acrF	3105	2598	98.5	acrF.l15.c4.ctg.2	3098	40.5	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1924	1924	T	55	T	54	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	700	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1188	31.6	1	SNP	p	R45C	0	.	.	133	135	CGC	457	459	CGC	62;65;63	C;G;C	62;65;63	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	598	acrS	663	663	98.64	acrS.l6.c4.ctg.1	1116	28.5	0	.	p	.	0	L34F	NONSYN	100	102	CTC	339	341	TTC	21;22;22	T;T;C	21;22;22	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	598	acrS	663	663	98.64	acrS.l6.c4.ctg.1	1116	28.5	0	.	p	.	0	E122G	NONSYN	364	366	GAG	603	605	GGG	39;40;39	G;G;G	39;40;39	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	794	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1179	36.0	0	.	p	.	0	V136L	NONSYN	406	408	GTT	595	597	CTT	58;58;59	C;T;T	57;57;59	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2414	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3176	40.8	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2106	2108	GCA	55;55;56	G;C;A	55;55;55	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2414	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3176	40.8	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2367	2369	ACC	36;36;36	A;C;C	36;35;35	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2414	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3176	40.8	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2676	2678	GCC	34;35;38	G;C;C	34;35;38	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1336	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2101	32.8	0	.	p	.	0	G37A	NONSYN	109	111	GGT	174	176	GCT	14;14;15	G;C;T	14;14;15	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1336	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2101	32.8	0	.	p	.	0	D77E	NONSYN	229	231	GAT	294	296	GAG	8;9;9	G;A;G	8;9;9	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1336	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2101	32.8	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	330	332	TGC	13;13;14	T;G;C	13;13;14	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1336	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2101	32.8	0	.	p	.	0	I150V	NONSYN	448	450	ATT	513	515	GTT	22;22;23	G;T;T	22;22;23	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1336	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2101	32.8	0	.	p	.	0	R200H	NONSYN	598	600	CGC	663	665	CAC	32;32;33	C,T;A;C	31,1;32;33	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1336	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2101	32.8	0	.	p	.	0	T295M	NONSYN	883	885	ACG	948	950	ATG	40;41;40	A;T;G	39;41;40	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1336	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2101	32.8	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1944	1946	CGC	20;20;21	C;G;C	20;20;21	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	620	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1285	25.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	887	889	ACC	23;23;24	A;C;C	23;23;24	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	620	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1285	25.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	899	901	TCG	30;31;33	T;C;G	30;31;33	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	600	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1300	24.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1024	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1976	27.8	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1417	1419	AAA	19;18;17	A;A;A	18;18;17	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1024	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1976	27.8	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1429	1431	GAG	11;10;10	G;A;G	11;10;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1024	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1976	27.8	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1435	1437	CAC	16;16;16	C,A;A;C	14,1;16;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1024	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1976	27.8	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1489	1491	GAG	26;26;26	G;A;G	26;26;26	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1134	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1856	32.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	722	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1172	33.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	830	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1483	30.0	0	.	p	.	0	A146T	NONSYN	436	438	GCT	682	684	ACT	33;34;36	A;C;T	33;34;36	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	508	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	923	29.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
dfrA5.3002861.DQ278190.0_474.2104	dfrA5.3002861.DQ278190.0_474.2104	1	0	27	472	dfrA5	474	474	100.0	dfrA5.l15.c30.ctg.1	890	27.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA5;dfrA5 is an integron-encoded dihydrofolate reductase found in Vibrio cholerae
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	958	emrA	1173	1173	98.29	emrA.l6.c4.ctg.1	1643	31.2	0	.	p	.	0	I219V	NONSYN	655	657	ATC	865	867	GTC	47;47;47	G;T;C	46;46;47	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1414	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	1966	38.4	0	.	p	.	0	E197K	NONSYN	589	591	GAA	837	839	AAA	37;38;37	A;A;A	37;37;35	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	986	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1675	31.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	826	828	AGC	38;37;36	A;G;C	37;37;35	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	68	emrE_1	333	216	91.2	emrE_1.l15.c30.ctg.2	253	4.5	0	.	p	.	0	I100V	NONSYN	298	300	ATT	182	184	GTC	3;2;2	G;T;C	3;2;2	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	68	emrE_1	333	216	91.2	emrE_1.l15.c30.ctg.2	253	4.5	0	.	p	.	0	T108A	NONSYN	322	324	ACA	206	208	GCA	2;2;2	G;C;A	2;2;2	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	856	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1659	27.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	763	765	AGG	31;31;31	A;G;G	31;31;31	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	856	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1659	27.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1153	1155	GAC	32;32;32	G;A;C	32;32;32	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	524	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1186	23.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1442	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	2017	38.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	562	evgA	615	615	99.19	evgA.l6.c4.ctg.1	1141	26.5	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	417	419	CTG	37;37;37	C;T;G	37;37;37	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	410	412	ATA	21;21;21	A;T;A	21;21;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	422	424	GTA	20;21;21	G;T;A	20;21;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	575	577	ACG	21;21;20	A;C;G	21;21;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	638	640	GAA	26;26;25	G;A;A	25;26;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	677	679	GCT	19;19;18	G;C;T	19;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	695	697	GAT	22;21;21	G;A;T	22;21;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	782	784	TCA	21;20;19	T;C;A	21;20;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	911	913	CAG	17;18;16	C;A;G	16;17;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1049	1051	GTT	18;18;18	G;T;T	17;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1205	1207	GAT	11;11;11	G;A;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1373	1375	AAT	18;18;18	A;A;T	18;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1394	1396	TTA	13;13;13	T;T;A	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1595	1597	AAA	14;15;16	A;A;A	14;15;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2330	2332	CAT	28;27;26	C;A;T	28;27;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2384	2386	CAT	31;31;30	C;A;T	31;31;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2402	2404	AGA	29;29;30	A;G;A	29;29;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2417	2419	AAT	31;28;26	A;A;T	31;28;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2564	2566	TCC	31;30;31	T;C;C	31;30;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2729	2731	ATT	35;30;28	A;T;T	35;30;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2750	2752	GAT	34;34;35	G;A;T	34;33;35	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2864	2866	GTT	35;35;34	G;T;T	35;35;34	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2470	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4118	32.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3149	3151	CAC	37;35;35	C;A;C	37;34;35	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	862	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1278	36.1	1	SNP	p	P64H	0	.	.	190	192	CCA	381	383	CCA	46;45;46	C;C;A	45;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	862	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1278	36.1	1	SNP	p	P64L	0	.	.	190	192	CCA	381	383	CCA	46;45;46	C;C;A	45;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	862	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1278	36.1	1	SNP	p	P64A	0	.	.	190	192	CCA	381	383	CCA	46;45;46	C;C;A	45;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	862	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1278	36.1	1	SNP	p	P64R	0	.	.	190	192	CCA	381	383	CCA	46;45;46	C;C;A	45;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	862	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1278	36.1	1	SNP	p	P64S	0	.	.	190	192	CCA	381	383	CCA	46;45;46	C;C;A	45;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	528	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1028	27.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	L46P	NONSYN	136	138	CTG	25	27	CCG	2;2;2	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	E54D	NONSYN	160	162	GAA	49	51	GAT	2;3;3	G;A;T	2;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	151	153	ATG	6;6;6	A;T;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	154	156	CCG	6;6;6	C;C;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	187	189	GAA	7;7;7	G;A;A	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	190	192	TCC	6;6;6	T;C;C	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	193	195	GGG	6;6;6	G;G;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	217	219	AAT	7;7;7	A;A;T	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	146	gadW	729	618	94.34	gadW.l15.c17.ctg.1	685	11.4	0	.	p	.	0	S234A	NONSYN	700	702	TCG	589	591	GCG	14;14;14	G;C;G	14;14;14	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	522	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1210	23.1	0	.	p	.	0	F53L	NONSYN	157	159	TTC	358	360	TTA	25;25;24	T;T;A	25;25;24	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	522	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1210	23.1	0	.	p	.	0	V79I	NONSYN	235	237	GTT	436	438	ATT	26;27;27	A;T;T	26;27;27	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	522	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1210	23.1	0	.	p	.	0	R246G	NONSYN	736	738	AGA	937	939	GGA	19;18;16	G;G;A	19;18;16	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	522	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1210	23.1	0	.	p	.	0	S248P	NONSYN	742	744	TCG	943	945	CCG	12;11;10	C;C;G	12;11;10	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2254	2256	GAA	40;42;42	G;A;A	40;42;42	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	S83W	0	.	.	247	249	TCG	469	471	TCG	44;44;49	T;C;G	44;44;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	S83L	0	.	.	247	249	TCG	469	471	TCG	44;44;49	T;C;G	44;44;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	S83I	0	.	.	247	249	TCG	469	471	TCG	44;44;49	T;C;G	44;44;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	481	483	GAC	48;47;47	G;A;C	46;45;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	D87H	0	.	.	259	261	GAC	481	483	GAC	48;47;47	G;A;C	46;45;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	D87N	0	.	.	259	261	GAC	481	483	GAC	48;47;47	G;A;C	46;45;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	D87G	0	.	.	259	261	GAC	481	483	GAC	48;47;47	G;A;C	46;45;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2342	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3067	41.0	1	SNP	p	D87V	0	.	.	259	261	GAC	481	483	GAC	48;47;47	G;A;C	46;45;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2012	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2910	37.1	1	SNP	p	R136I	0	.	.	406	408	CGC	657	659	CGC	48;46;45	C;G;C	47;46;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2012	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2910	37.1	1	SNP	p	R136S	0	.	.	406	408	CGC	657	659	CGC	48;46;45	C;G;C	47;46;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2012	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2910	37.1	1	SNP	p	R136H	0	.	.	406	408	CGC	657	659	CGC	48;46;45	C;G;C	47;46;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2012	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2910	37.1	1	SNP	p	R136C	0	.	.	406	408	CGC	657	659	CGC	48;46;45	C;G;C	47;46;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2012	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2910	37.1	1	SNP	p	R136L	0	.	.	406	408	CGC	657	659	CGC	48;46;45	C;G;C	47;46;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2012	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2910	37.1	1	SNP	p	R136E	0	.	.	406	408	CGC	657	659	CGC	48;46;45	C;G;C	47;46;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2012	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2910	37.1	1	SNP	p	R136G	0	.	.	406	408	CGC	657	659	CGC	48;46;45	C;G;C	47;46;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	512	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1146	23.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	465	467	CCG	23;23;23	C;C;G	23;22;23	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	512	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1146	23.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	618	620	GCC	30;31;31	G,C;C;C	29,1;31;31	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	808	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1451	29.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	222	224	TCA	11;11;11	T;C;A	11;10;11	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	372	marA	384	384	99.74	marA.l6.c17.ctg.1	845	23.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	593	595	AGC	16;15;15	A;G;C	16;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	695	697	CAT	7;8;9	C;A;T	7;6;9	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	V45E	0	.	.	133	135	GTG	419	421	GTG	40;40;41	G;T;G	39;40;41	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	I49S	0	.	.	145	147	ATC	431	433	ATC	38;37;36	A;T;C	38;36;36	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	A70T	0	.	.	208	210	GCA	494	496	GCA	35;35;36	G;C;A	34;34;36	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	R73C	0	.	.	217	219	CGT	503	505	CGT	38;37;37	C;G;T	38;37;37	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	R73S	0	.	.	217	219	CGT	503	505	CGT	38;37;37	C;G;T	38;37;37	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	R77L	0	.	.	229	231	CGC	515	517	CGC	37;37;37	C;G;C	37;36;37	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	R77C	0	.	.	229	231	CGC	515	517	CGC	37;37;37	C;G;C	37;36;37	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	L78M	0	.	.	232	234	CTG	518	520	CTG	37;37;37	C;T;G	37;37;37	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	R94H	0	.	.	280	282	CGC	566	568	CGC	16;16;15	C;G;C	16;16;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	R94S	0	.	.	280	282	CGC	566	568	CGC	16;16;15	C;G;C	16;16;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	854	17.0	1	SNP	p	V96E	0	.	.	286	288	GTA	572	574	GTA	14;14;13	G;T;A	14;14;12	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	S7F	NONSYN	19	21	TCC	21	23	TTC	6;6;6	T;T;C	6;5;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	R36I	NONSYN	106	108	AGG	108	110	ATC	13;13;13	A;T;C	13;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	E42A	NONSYN	124	126	GAA	126	128	GCC	6;7;7	G;C;C	6;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	N43V	NONSYN	127	129	AAT	129	131	GTG	7;7;7	G;T;G	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	156	158	GAT	11;11;12	G;A;T	11;11;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	177	179	ACC	15;15;14	A;C;C	15;15;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	I68L	NONSYN	202	204	ATA	204	206	TTA	15;15;14	T;T;A	15;15;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	345	347	CAG	37;37;37	C;A;G	37;36;37	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	384	386	GCC	41;41;41	G;C;C	41;41;40	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	489	491	GCG	34;33;34	G;C;G	34;32;34	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	693	695	GTT	25;26;25	G;T;T	22;22;25	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	744	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1499	26.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	855	855	C	26	C	25	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	768	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1688	24.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	264	264	G	19	G	19	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	768	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1688	24.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	321	323	CAG	19;20;20	C;A;G	19;19;20	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	768	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1688	24.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	471	473	ATC	20;20;19	A;T;C	19;20;19	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	768	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1688	24.4	0	.	p	.	0	R91C	NONSYN	271	273	CGC	495	497	TGC	17;17;16	T;G;C	17;17;16	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	768	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1688	24.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	519	521	ATG	19;20;20	A;T;G	19;20;20	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	768	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1688	24.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	612	614	ACC	26;25;25	A;C;C	26;24;25	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	768	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1688	24.4	0	.	p	.	0	P257T	NONSYN	769	771	CCG	993	995	ACG	34;34;34	A;C;G	34;33;34	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2582	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3622	38.3	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1979	1981	ACC	56;55;53	A;C;C	56;55;52	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2582	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3622	38.3	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2372	2374	CAA	29;30;32	C;A;A	29;30;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2582	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3622	38.3	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2540	2542	ATT	35;34;35	A;T;T	35;34;35	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2582	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3622	38.3	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2624	2626	GTT	26;25;24	G;T;T	26;25;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2582	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3622	38.3	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2732	2734	GAG	30;32;34	G;A;G	29;32;33	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2582	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3622	38.3	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2960	2962	ATG	31;31;30	A;T;G	31;31;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2582	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3622	38.3	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3095	3097	GAT	44;45;46	G;A;T	43;44;45	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2282	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3517	34.9	0	.	p	.	0	I46M	NONSYN	136	138	ATC	369	371	ATG	20;20;20	A;T;G	20;20;20	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2282	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3517	34.9	0	.	p	.	0	V208I	NONSYN	622	624	GTC	855	857	ATC	29;30;35	A,G;T;C	27,1;29;34	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2282	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3517	34.9	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3171	3173	CAC	11;11;11	C;A;C	11;10;11	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2282	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3517	34.9	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3174	3176	CTC	11;11;10	C;T;C	11;11;10	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1132	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1924	31.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	221	223	GAA	18;18;18	G;A;A	17;17;18	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1132	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1924	31.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	890	892	GCG	43;43;44	G;C;G	43;43;44	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1132	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1924	31.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1232	1234	ATC	42;41;39	A;T,G;C	42;40,1;38	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1132	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1924	31.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1535	1537	TTT	38;39;36	T;T;T	38;39;36	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1162	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1667	37.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2600	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3683	38.0	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1175	1177	ACC	33;33;33	A;C;C	33;33;33	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2600	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3683	38.0	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2417	2419	GAC	37;37;37	G;A;C	37;36;37	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1038	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.1	574	18.1	0	.	p	.	0	E5G	NONSYN	13	15	GAA	181	183	GGA	16;17;17	G;G;A	16;17;17	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1038	mdtG	1227	1047	99.24	mdtG.l15.c4.ctg.2	1506	29.5	0	.	p	.	0	A132T	NONSYN	394	396	GCC	423	425	ACC	25;24;24	A;C;C	24;24;23	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1038	mdtG	1227	1047	99.24	mdtG.l15.c4.ctg.2	1506	29.5	0	.	p	.	0	V200I	NONSYN	598	600	GTC	627	629	ATC	32;32;33	A;T;C	32;32;33	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	964	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1638	31.5	0	.	p	.	0	G134C	NONSYN	400	402	GGT	679	681	TGT	37;37;35	T;G;T	36;37;35	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	964	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1638	31.5	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1249	1251	TTG	31;31;31	T;T;G	30;30;30	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	964	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1638	31.5	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1459	1461	ACG	15;15;14	A;C;G	15;15;14	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1000	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1737	30.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	836	838	TCC	30;31;32	T;C;C	29;29;31	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	726	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1641	23.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	665	667	ATT	24;23;22	A;T;T	24;23;22	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	V11M	NONSYN	31	33	GTG	234	236	ATG	16;17;18	A;T;G	16;17;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	T33I	NONSYN	97	99	ACC	300	302	ATC	18;20;22	A;T;C	18;20;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	C116R	NONSYN	346	348	TGC	549	551	CGC	36;36;34	C;G;C	36;36;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	N238S	NONSYN	712	714	AAC	915	917	AGC	44;44;45	A;G;C	44;44;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1116	1118	GTG	29;29;28	G;T;G	29;28;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1179	1181	AAC	28;26;26	A;A;C	26;23;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1224	1226	GTC	30;28;28	G;T;C	30;28;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1254	1256	ATA	34;34;34	A;T;A	34;34;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1362	1364	TCT	31;32;32	T;C;T	31;31;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1749	1751	GCG	31;31;32	G;C;G	31;29;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1508	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2509	32.2	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1962	1964	ATC	42;40;40	A;T;C	42;40;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	S129A	NONSYN	385	387	TCA	567	569	GCG	28;26;28	G;C;G	27;26;28	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	A187T	NONSYN	559	561	GCC	741	743	ACC	42;42;42	A;C;C	42;42;42	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	H211R	NONSYN	631	633	CAC	813	815	CGC	27;27;26	C;G;C	27;27;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	V250A	NONSYN	748	750	GTT	930	932	GCT	33;32;32	G;C;T	33;32;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1014	1016	AAA	23;22;20	A;A;A	23;22;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1032	1034	CGA	20;20;18	C;G;A	20;20;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1197	1199	GCC	25;24;23	G;C;C	25;23;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1209	1211	GAT	22;25;28	G;A;T	22;25;27	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1679	31.2	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1626	1628	GCT	19;19;19	G;C;T	19;19;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2720	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3866	37.8	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1515	1517	AAG	21;22;22	A;A;G	21;22;22	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2720	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3866	37.8	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2592	2594	CTG	27;28;29	C,A;T;G	26,1;27;29	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	196	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	658	15.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1582	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2095	40.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	924	926	AAC	34;34;36	A;A;C	34;33;35	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1582	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2095	40.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1470	1472	ATA	37;37;38	A;T;A	36;37;38	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1160	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1707	36.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1317	1319	GAT	49;49;51	G;A;T	49;48;51	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1160	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1707	36.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1320	1322	CTG	51;49;48	C;T;G	51;49;48	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	267	269	TGT	27;26;25	T;G;T	27;26;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	537	539	ACC	43;42;40	A;C;C	42;42;39	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	747	749	GAC	40;39;39	G;A;C	39;39;38	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	0	.	p	.	0	R208L	NONSYN	622	624	CGC	810	812	CTC	24;25;25	C;T;C	23;23;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	1	SNP	p	R15C	0	.	.	43	45	CGC	231	233	CGC	40;38;37	C;G;C	40;38;37	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	1	SNP	p	S33R	0	.	.	97	99	AGC	285	287	AGC	33;33;34	A;G;C	33;33;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	1	SNP	p	G131D	0	.	.	391	393	GGC	579	581	GGC	32;32;33	G;G;C	32;32;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	1	SNP	p	R203C	0	.	.	607	609	CGT	795	797	CGT	32;31;31	C;G;T	32;30;31	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	578	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	1113	27.6	1	SNP	p	R203L	0	.	.	607	609	CGT	795	797	CGT	32;31;31	C;G;T	32;30;31	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1164	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1546	40.2	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1188	1190	GAG	55;56;58	G;A;G	54;56;57	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1164	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1546	40.2	1	SNP	p	G141E	0	.	.	421	423	GGT	675	677	GGT	56;55;54	G;G;T	56;55;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1164	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1546	40.2	1	SNP	p	G141D	0	.	.	421	423	GGT	675	677	GGT	56;55;54	G;G;T	56;55;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1164	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1546	40.2	1	SNP	p	R154A	0	.	.	460	462	CGT	714	716	CGT	52;54;53	C;G;T	52;54;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1164	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1546	40.2	1	SNP	p	R154D	0	.	.	460	462	CGT	714	716	CGT	52;54;53	C;G;T	52;54;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2106	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2647	42.6	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1838	1840	GTG	53;53;52	G;T,C;G	52;51,1;51	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2106	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2647	42.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1865	1867	TCG	52;52;53	T;C,A;G	50;49,2;51	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2106	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2647	42.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2480	2482	AAC	23;23;23	A;A;C	23;23;23	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2106	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2647	42.6	1	SNP	p	A85T	0	.	.	253	255	GCG	494	496	GCG	44;44;44	G;C;G	44;44;44	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2106	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2647	42.6	1	SNP	p	D111H	0	.	.	331	333	GAT	572	574	GAT	32;32;33	G;A;T	32;32;33	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2106	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2647	42.6	1	SNP	p	S129P	0	.	.	385	387	TCC	626	628	TCC	32;35;34	T;C;C	32;35;33	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1278	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2475	27.7	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1734	1736	AAC	29;33;32	A;A;C	29;32;32	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1278	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2475	27.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1743	1745	GAT	35;35;35	G;A;T	35;35;35	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1274	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1987	34.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	945	947	CAG	47;46;48	C;A;G	46;46;48	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1274	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1987	34.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1419	1421	GAT	39;40;40	G;A;T	39;39;40	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	V146F	0	.	.	436	438	GTT	677	679	GTT	52;51;50	G;T;T	51;51;50	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1778	1780	CAG	48;49;49	C;A,C;G	48;47,1;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1778	1780	CAG	48;49;49	C;A,C;G	48;47,1;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1817	1819	CAC	37;37;37	C;A;C	37;36;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1826	1828	CGT	36;37;35	C;G;T	36;37;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1826	1828	CGT	36;37;35	C;G;T	36;37;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1832	1834	TCC	36;35;36	T;C;C	36;35;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1838	1840	CTC	35;34;35	C;T;C	35;34;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1928	1930	ACC	47;47;47	A;C;C	47;47;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1931	1933	CCT	49;50;51	C;C;T	49;50;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3686	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4528	43.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2300	2302	CGT	64;67;66	C;G;T	63;67;65	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	.	n	.	0	A226G	SNP	226	226	A	312	312	G	333	G	331	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	1	SNP	n	A794G	0	.	.	794	794	A	880	880	A	321	A	315	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	1	SNP	n	A794T	0	.	.	794	794	A	880	880	A	321	A	315	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	1	SNP	n	G926A	0	.	.	926	926	G	1012	1012	G	286	G	286	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	1	SNP	n	G926C	0	.	.	926	926	G	1012	1012	G	286	G	286	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	1	SNP	n	G926T	0	.	.	926	926	G	1012	1012	G	286	G	286	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	A79G	.	79	79	A	165	165	A	284	A,G	210,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	C719T	.	719	719	C	805	805	C	303	C,T	179,124	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	T273A	.	273	273	T	359	359	T	283	T,A	206,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	C183T	.	183	183	C	269	269	C	323	C,T	217,103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	A250T	.	250	250	A	336	336	A	281	A,T	216,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	T90C	.	90	90	T	176	176	T	289	T,C	213,71	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	G474A	.	474	474	G	560	560	G	330	G,A	256,70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	A253T,G	.	253	253	A	339	339	A	282	A,T,G	219,60,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1087	309.5	0	HET	.	.	.	C194T	.	194	194	C	280	280	C	351	C,T	274,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	125	100.0	rrsB+.l15.c17.ctg.2	125	62.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.3	532	328.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	495	495	A	214	A	213	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.3	532	328.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	495	495	A	214	A	213	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.3	532	328.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	495	495	A	214	A	213	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.3	532	328.9	0	HET	.	.	.	C1038T	.	1038	1038	C	14	14	C	166	C,T	52,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	128	95.35	rrsB+.l15.c17.ctg.6	128	64.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	89	A	88	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	128	95.35	rrsB+.l15.c17.ctg.6	128	64.0	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	87	C	87	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	128	95.35	rrsB+.l15.c17.ctg.6	128	64.0	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	94	C	94	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	128	95.35	rrsB+.l15.c17.ctg.6	128	64.0	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	96	G	96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	128	95.35	rrsB+.l15.c17.ctg.6	128	64.0	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	92	G	91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10640	rrsB+	1542	128	95.35	rrsB+.l15.c17.ctg.6	128	64.0	0	HET	.	.	.	C1038T	.	1038	1038	C	90	90	C	62	C,T	6,56	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	612	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1056	30.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	496	soxR	465	465	100.0	soxR.l15.c30.ctg.1	971	27.3	1	SNP	p	R20H	0	.	.	58	60	CGC	300	302	CGC	54;56;56	C;G;C	54;55;56	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	496	soxR	465	465	100.0	soxR.l15.c30.ctg.1	971	27.3	1	SNP	p	G121D	0	.	.	361	363	GGT	603	605	GGT	35;35;35	G;G;T	35;35;35	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	338	soxS_1	324	324	99.69	soxS_1.l6.c30.ctg.1	893	20.1	1	SNP	p	A12S	0	.	.	34	36	GCA	282	284	GCA	42;41;42	G;C;A	42;41;42	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	6708	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c30.ctg.1	1374	261.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	6376	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c30.ctg.1	1347	253.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul1.manually_added_NC_002134_NP_052895.3_12192_13058	sul1.manually_added_NC_002134_NP_052895.3_12192_13058	1	0	27	622	sul1	867	867	100.0	sul1.l15.c4.ctg.1	1287	25.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_002134.1 Shigella flexneri 2b plasmid R100 DNA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	5394	sul2	816	816	100.0	sul2.l6.c30.ctg.1	1404	206.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	7450	tetA	1200	1200	100.0	tetA.l6.c30.ctg.1	1832	218.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	4500	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1165	207.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1402	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2014	37.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
